[{"Assets_0_Q3_USD":"1079246000.0","CIK":"1737287","CommonStockSharesConverted_0_Q3_shares":"142439829.0","CommonStockSharesOutstanding_0_Q3_shares":"142439829.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.57","EarningsPerShareBasic_3_Q3_USD":"-1.35","EarningsPerShareDiluted_1_Q3_USD":"-0.57","EarningsPerShareDiluted_3_Q3_USD":"-1.35","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-139376000.0","NetIncomeLoss_1_Q3_USD":"-78186000.0","NetIncomeLoss_3_Q3_USD":"-182137000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","ProfitLoss_3_Q3_USD":"-182137000.0","RevenuesConverted_1_Q3_USD":"49000.0","RevenuesConverted_3_Q3_USD":"38438000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"969942000.0","Ticker":"ALLO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"137025698.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"134690310.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"137025698.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"134690310.0","filed":"20211104","footnote":null,"form":"10-Q","fp":"Q3","fy":"2021.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20210930","qtrs":"0","uom":"USD"}]